Related references
Note: Only part of the references are listed.Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
Shannon Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Visualizing and interpreting cancer genomics data via the Xena platform
Mary J. Goldman et al.
NATURE BIOTECHNOLOGY (2020)
Integrated Analysis of Prognostic and Immune Associated Integrin Family in Ovarian Cancer
Anqi Wu et al.
FRONTIERS IN GENETICS (2020)
Targeting Alterations in the RAF-MEK Pathway
Rona Yaeger et al.
CANCER DISCOVERY (2019)
ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer
Yan Jiao et al.
ONCOTARGETS AND THERAPY (2019)
Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer
Myung-Chul Lee et al.
ENDOCRINOLOGY AND METABOLISM (2019)
LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers
Jing-Hua Pan et al.
FRONTIERS IN IMMUNOLOGY (2019)
Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations
Mardiaty Iryani Abdullah et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2019)
Overexpression of HER2/HER3 and clinical feature of ovarian cancer
Ye Won Chung et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2019)
Radioiodine refractory differentiated thyroid cancer
Yuchen Jin et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma
Yu Huang et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Posttranscriptional upregulation of HER3 by HER2 mRNA induces trastuzumab resistance in breast cancer
Xin Li et al.
MOLECULAR CANCER (2018)
The expression profile of integrin receptors and osteopontin in thyroid malignancies varies depending on the tumor progression rate and presence of BRAF V600E mutation
Galina Chernaya et al.
SURGICAL ONCOLOGY-OXFORD (2018)
Intermediate-Risk Papillary Thyroid Cancer: Risk Factors for Early Recurrence in Patients with Excellent Response to Initial Therapy
Augusto Enrique Llamas-Olier et al.
THYROID (2018)
The History of the Follicular Variant of Papillary Thyroid Carcinoma
Giovanni Tallini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma
Jong-Lyel Roh et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Race-Specific Molecular Alterations Correlate With Differential Outcomes for Black and White Endometrioid Endometrial Cancer Patients
Nicholas W. Bateman et al.
CANCER (2017)
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li et al.
CANCER RESEARCH (2017)
Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer
Keiichi Koshizuka et al.
CANCER SCIENCE (2017)
Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer
Takashi Sakaguchi et al.
BRITISH JOURNAL OF CANCER (2017)
Systematic Review of Trends in the Incidence Rates of Thyroid Cancer
Joseph J. Wiltshire et al.
THYROID (2016)
The role of HER3 in gastric cancer
Liying Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2014)
PlantGSEA: a gene set enrichment analysis toolkit for plant community
Xin Yi et al.
NUCLEIC ACIDS RESEARCH (2013)
Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy
Libero Santarpia et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
American Thyroid Association Consensus Review and Statement Regarding the Anatomy, Terminology, and Rationale for Lateral Neck Dissection in Differentiated Thyroid Cancer
Brendan C. Stack et al.
THYROID (2012)
Central Lymph Node Metastasis of Unilateral Papillary Thyroid Carcinoma: Patterns and Factors Predictive of Nodal Metastasis, Morbidity, and Recurrence
Jong-Lyel Roh et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Raf kinases in cancer-roles and therapeutic opportunities
G. Maurer et al.
ONCOGENE (2011)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
Specific Cross-talk between Epidermal Growth Factor Receptor and Integrin αvβ5 Promotes Carcinoma Cell Invasion and Metastasis
Jill M. Ricono et al.
CANCER RESEARCH (2009)
Reorganization of the integrin alpha 2 subunit controls cell adhesion and cancer cell invasion in prostate cancer
Severine Van Slambrouck et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
HER3 is a determinant for poor prognosis in melanoma
Markus Reschke et al.
CLINICAL CANCER RESEARCH (2008)
Laminin isoforms and their integrin receptors in glioma cell migration and invasiveness:: Evidence for a role of α5-laminin(s) and α3β1 integrin
Tomoyuki Kawataki et al.
EXPERIMENTAL CELL RESEARCH (2007)
β4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis
Wenjun Guo et al.
CELL (2006)
Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk
U Langsenlehner et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Clinically significant prognostic factors for differentiated thyroid carcinoma - A population-based, nested case-control study
CI Lundgren et al.
CANCER (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
ONCOMINE: A cancer microarray database and integrated data-mining platform
DR Rhodes et al.
NEOPLASIA (2004)
Laminin-10 mediates basal and EGF-stimulated motility of human colon carcinoma cells via α3β1 and α6β4 integrins
N Pouliot et al.
EXPERIMENTAL CELL RESEARCH (2001)
Share Paper
